Notably, the tumor was negative for ER and PR, in contrast to the high positivity rates reported in a multicenter retrospective study of 63 cases by Agni et al. [10] where ER and PR positivity rates were 98.2% and 96.1%, respectively. This evidence concerns the gene ESR1 and neoplasm.